EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Phytochemistry, Ethnobotanical, and Pharmacological Potentials of the Medicinal Plant-Vernonia amygdalina L. (bitter Leaf)

Eziuche A. Ugbogu, Okezie Emmanuel, Emmanuel D. Dike, Grace O. Agi, Ositadimma C. Ugbogu, Chibuike Ibe, Emeka J. Iweala

Clinical Complementary Medicine and Pharmacology · 2021-12 · 1 (1) · 100006

DOI: 10.1016/j.ccmp.2021.100006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Complementary Medicine and Pharmacology, 2021-12. Verfasst von Eziuche A. Ugbogu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vernonia amygdalina is traditionally used to treat a variety of diseases including diarrhoea, fungal and bacterial infections, inflammation, cancer, diabetes, and its squeezed juice can be applied on wounds. This study reviewed the phytochemistry, ethnopharmacological, and pharmacological potentials of V. amygdalina. Literature search of relevant papers (1994-2021) were performed using ScienceDirect, Springer, Wiley and PubMed databases. For this review study, only publications written in English were utilized. The bioactive compounds extracted from V. amygdalina includes 6β,10β,14β trimethylheptadecan-15 α-olyl-15-O-β-D-glucopyranosyl-1,5 β olide, glucuronolactone, 11 α-hydroxyurs-5,12-dien-28-oic acid-3 α,25-olide, 10-geranilanyl-O-β-D-xyloside, 1-heneicosenol O-β-D-glucopyranoside, apigenin, luteolin (3´,4´,5,7tetrahydroxyflavone), vernolide, hydroxyvernolide, 3′-deoxyvernodalol , vernodalol, diterpene (ingenol-3-angelate), vernomygdin, 4-methylumbelliferone, cephantharin, cryptolepine, isocryptolepine, neocryptolepine, courmarins, vernolepin, and vernoniosides. Various in vivo and in vitro studies revealed that V. amygdalina and its bioactive components possess pharmacological activities such as antioxidant, anti-inflammatory, anticancer, antimicrobial, hepatoprotective,antidiarrheal, anti-diabetic, and neuroprotective activities. This review demonstrated that V. amygdalina possess therapeutic effects against a wide variety of diseases. The efficacy of V. amygdalina in ameliorating diseases is attributed to its antioxidant activity and ability to improve the antioxidant system. Despite the vast pharmacological activities of V. amygdalina, more human clinical trials are needed to identify effective and safe doses for treatment of various diseases.

Zitieren

APA

Ugbogu, E. A., Emmanuel, O., Dike, E. D., Agi, G. O., Ugbogu, O. C., Ibe, C., & Iweala, E. J. (2021). The Phytochemistry, Ethnobotanical, and Pharmacological Potentials of the Medicinal Plant-Vernonia amygdalina L. (bitter Leaf). Clinical Complementary Medicine and Pharmacology, 1(1), 100006. https://doi.org/10.1016/j.ccmp.2021.100006

Vancouver

Ugbogu EA, Emmanuel O, Dike ED, Agi GO, Ugbogu OC, Ibe C, et al. The Phytochemistry, Ethnobotanical, and Pharmacological Potentials of the Medicinal Plant-Vernonia amygdalina L. (bitter Leaf). Clinical Complementary Medicine and Pharmacology. 2021;1(1):100006. doi:10.1016/j.ccmp.2021.100006

BibTeX
@article{Ugbogu2021,
  author = {Ugbogu, Eziuche A. and Emmanuel, Okezie and Dike, Emmanuel D. and Agi, Grace O. and Ugbogu, Ositadimma C. and Ibe, Chibuike and Iweala, Emeka J.},
  title = {The Phytochemistry, Ethnobotanical, and Pharmacological Potentials of the Medicinal Plant-Vernonia amygdalina L. (bitter Leaf)},
  journal = {Clinical Complementary Medicine and Pharmacology},
  year = {2021},
  volume = {1},
  number = {1},
  pages = {100006},
  doi = {10.1016/j.ccmp.2021.100006}
}
Kostenlos starten →